Curated News
By: NewsRamp Editorial Staff
August 06, 2025

Nutriband Innovates with Abuse-Deterrent Fentanyl Patch

Reddit Discuss on LinkedIn Discuss on Substack participate in discussion on bluesky Participate in discussion on Mastodon View History of this news story on GitHub
Original Source

TLDR

  • Nutriband's Aversa(TM) fentanyl patch offers a competitive edge in the pharmaceutical market with an estimated annual potential of $80 to $200 million.
  • Nutriband is developing Aversa(TM), a transdermal technology designed to prevent misuse of fentanyl through innovative abuse-deterrent mechanisms.
  • Aversa(TM) by Nutriband aims to enhance patient safety and reduce opioid abuse, contributing to a healthier society.
  • Discover how Nutriband's Aversa(TM) technology is revolutionizing fentanyl delivery with abuse-deterrent features to combat misuse.

Impact - Why it Matters

The development of abuse-deterrent technologies like Nutriband's Aversa(TM) fentanyl patch is critical in addressing the opioid crisis. By preventing misuse and accidental exposure, this innovation not only saves lives but also reduces the societal and economic burdens associated with opioid abuse. It represents a significant step forward in pharmaceutical safety and patient care.

Summary

Nutriband Inc. (NASDAQ: NTRB) is making waves in the pharmaceutical industry with its innovative Aversa(TM) technology, a groundbreaking abuse-deterrent transdermal system designed to combat the misuse and accidental exposure of potent opioids like fentanyl. With fentanyl being 50 times more potent than heroin, the development of safe and effective delivery systems is crucial. Nutriband's Aversa(TM) fentanyl patch not only addresses this critical need but also boasts an estimated market potential of $80 million to $200 million annually within five years of launch. This initiative places Nutriband at the forefront of tackling one of modern healthcare's most pressing challenges. For more insights into Nutriband's pioneering efforts, Read More>>.

The company's efforts are supported by BioMedWire, a specialized communications platform that highlights the latest in Biotechnology and Life Sciences, ensuring that Nutriband's advancements reach a wide audience of investors and the general public. Discover more about Nutriband's journey and its potential impact on the pharmaceutical industry by visiting Nutriband (NASDAQ: NTRB).

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Nutriband Innovates with Abuse-Deterrent Fentanyl Patch

blockchain registration record for this content.